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Edited by Veli-Pekka LehtoAbstract The transcription factor NF-jB is frequently acti-
vated in cancer, and is therefore a valuable target for cancer
therapy. Decoy oligodeoxynucleotides (ODNs) inhibit NF-jB
by preventing its binding to the promoter region of target genes.
Few studies have used NF-jB-targeting with ODNs in cancer.
Using a hairpin NF-jB-decoy ODN we found that it induced
growth inhibition and cell death in NF-jB-dependent tumour cell
lines. The ODN colocalized with the p50 subunit of NF-jB in
cells and directly interacted with it in nuclear extracts. In
TNFa-treated cells the ODN and the p50 subunit were found
in the cytoplasm suggesting that the complex did not translocate
to the nucleus. Transcriptional activity of NF-jB was eﬃciently
inhibited by the ODN, whereas a scrambled ODN was without
eﬀect on transcription. Thus, ODN-mediated inhibition of NF-
jB can eﬃciently promote cell death in cancer cells providing
a potentially powerful approach to tumour growth inhibition.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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NF-jB is a transcription factor regulating the expression of
a wide variety of genes that activate innate and adaptive immu-
nity, angiogenesis, cell adhesion and inﬂammation. NF-jB is
involved in many cancers: constitutively active NF-jB has
been detected in human tumour cell lines and in tumour tissues
derived from patients (reviewed in [1]), such as multiple myelo-
ma, acute myeloblastic leukemia, acute lymphoblastic leuke-
mia, prostate, breast cancers and colon cancers [2–4].
Activation of NF-jB makes it a valuable target for cancer
therapy. Various pharmacological inhibitors of the NF-jB sig-
naling pathway include inhibitors of the proteasome [5], inhib-
itors of the IKKs (aspirin, sulfasalazine, and sulindac) that
result in trapping the NF-jB precursor subunits in the cyto-*Corresponding author. Fax: +33 0 148955627.
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or thalidomide, inhibit the NF-jB pathway through unidenti-
ﬁed mechanisms [5]. Alternatively, the NF-jB pathway is
inhibited by peptides designed to interact with the nuclear
localization sequence of the p50 subunit of NF-jB. For exam-
ple, cell-permeable peptide SN50 reduced NF-jB DNA bind-
ing and increased apoptosis in retinoblastoma and multiple
myeloma cells [6]. Decoy oligodeoxynucleotides (ODNs) result
in potentially highly speciﬁc NF-jB antagonism by preventing
its binding to the promoter region of target genes. Indeed, inhi-
bition of NF-jB by ODNs was achieved in a cystic ﬁbrosis epi-
thelial cell line [7], in allografts [8–10] and in animal models of
cardiovascular disease and ischemia–reperfusion injury [11–15]
and intimal hyperplasia [16]. The decoy therapy was also used
for the treatment of asthma [17], rheumatoid arthritis [18] and
atopic dermatitis [19]. In cancer, the inhibition of NF-jB by
antisense ODNs interfered with the adhesion of cells and
caused tumour regression in vitro and in vivo [20]. Previously,
injections of phosphodiester NF-jB ODNs in the tumours of
mice was shown to have no inﬂuence on the growth of the tu-
mours [21], whereas a phosphorothioate NF-jB decoy ODN
was found to sensitize MCF7 cells to anti-cancer drugs [22].
However, the relationship between the interaction of an
ODN with NF-jB within cancer cells and the eﬀect on growth
has not been thoroughly studied. Previously, we showed that a
hairpin NF-jB decoy ODN that could covalently bind the p50
subunit of NF-jB could induce cell death in cells in culture,
however, substantial eﬃciency was diﬃcult to achieve proba-
bly as the result of intracellular thioredoxin-based reducing
systems [23]. The aim of this study was to evaluate the inhibi-
tion of NF-jB by a hairpin NF-jB decoy ODN and to analyse
the interaction of the ODN with the transcription factor. In
order to allow analysis of the cells, low concentrations of the
hairpin decoy ODN were used. We tested the hairpin NF-jB
decoy ODNs on two cell lines that are dependent on NF-jB
for their growth (SW480 and MCF7) and on a cell line that
is independent on NF-jB (2C4).
In this report, we show the ability of a hairpin NF-jB-decoy
ODN to reduce the growth of NF-jB-dependent cancer
cells, we show colocalization of the hairpin decoy ODN
with NF-jB in these cells, and show the ability of the hair-
pin decoy ODN to block the transcriptional activity of NF-
jB.blished by Elsevier B.V. All rights reserved.
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2.1. Cell culture
MCF7 (breast), SW480 (colon), 2C4 (ﬁbrosarcoma) cell lines were
grown in 10%FCS/ DMEM (GibcoBRL, Life technologies, Cergy-
Pontoise, France), 100 U/mL penicillin, 10 lg/mL streptomycin
(GibcoBRL), 1 mM sodium pyruvate (GibcoBRL), MEM vitamins
100· (GibcoBRL) and 5 lg/mL plasmocin (Cayla InvivoGen,
Toulouse, France). Chemicals: the NF-jB inhibitor Bay 11 was from
Bayer AG (France), curcumin was from Acros organics (Halluin,
France).
2.2. Synthesis of the hairpin NF-jB decoy ODN
The following oligonucleotides were used in this study: RNH(CH2)6-
CTGGAAAGTCCCTCGAAGAGGGACTTTCCAG-(CH2)3NHR
(hairpin NF-jB decoy ODN) and RHN(CH2)6-TGCAGTCAC-
TACGCGAAGCGTAGTGACTGCA-(CH2)3NHR (hairpin scram-
bled ODN) where R is either H, Cy3 or biotin. Synthesis of decoy
oligonucleotides with R = H and Cy3 was published elsewhere [24].
To synthesize oligonucleotides with R = biotin 7–10 nanomoles of
the oligonucleotide bearing 3 0- and 5 0-aminoalkyl linkers were dis-
solved in 20 lL of 0.1 M NaHCO3. EZ-Link NHS-Biotin (Pierce)
(10 lL of a 65 mM solution in dimethyl sulfoxide) was added, and
the mixture was incubated at room temperature for 6–16 h in the dark.
Then 25 lL of water were added, and the modiﬁed oligonucleotide was
separated from the excess of hydrolyzed reagent by two consecutive
separations onMicro Bio-Spin 6 columns following the manufacturer’s
recommendations. After the second spin, the biotinylated oligonucleo-
tide was precipitated with ethanol–sodium acetate.
2.3. Preparation of liposomes
Liposomes were formulated using a cationic lipid (3b-[N-(N 0,N 0,N 0-
triethylaminopropane)-carbamoyl] cholesterol) iodide (TEAPC-Chol)
and neutral colipid dioleoyl phosphatidylethanolamine (DOPE), as
previously described [25]. Brieﬂy, TEAPC-Chol and colipid (DOPE)
were mixed at a ratio of 1:1 (w/w) and dissolved in chloroform. The
solution was dried in vacuum. Sterile water was then added and the
mixture was sonicated to clarity for 1 h in cycles of 15 min. Using
light scattering we found that the size distribution of the liposomes
was unimodal. The concentration of cationic lipid was monitored
by UV spectroscopy at 226 nm and the value was used to calculate
the charge ratio assuming one positive charge for each cationic lipid
molecule.
2.4. Transfection using liposomes
Cells were grown in 96-wells plates to a density of 1 million cells/
mL. When the cells reached 50–60% conﬂuence, they were transfected
with the hairpin NF-jB decoy ODN or the hairpin scrambled ODN
(0.5, 1 and 2 lg corresponding to 100, 200 and 400 nM, respectively)
in 100 lL of DMEM medium (without SVF) combined to the lipo-
somes (0.5, 1 or 2 lg of cationic lipid) thus yielding liposomes/ODN
ratios of 0.5/0.5, 2/2, 1/0.5 and 1/1 (lg/lg). After 6 h at 37 C in a
humidiﬁed 5% CO2 incubator, the cells were placed in fresh serum-
containing medium. Expression was analysed after 24 h. In control
experiments, the liposomes were used alone at the same lipid concen-
trations.2.5. Flow cytometry
The uptake of FITC-labeled hairpin NF-jB decoy ODN was mea-
sured by ﬂow cytometry, gating on FL1-positive signal on EPICS
XL Beckman-Coulter counter (Beckman Coulter, Villepinte, France).
To measure the rate of cell death, cells were resuspended in annexin
V-binding buﬀer, incubated with 5 lL of FITC-labeled annexin V
(BD Pharmingen, Morangis, France) and 5 lL of propidium iodide
and analysed in a EPICS XL Beckman-Coulter counter.2.6. Cell viability
Cell viability was determined using the Cell Titer-Glo kit (Promega-
France, Charbonnie`res, France), following the manufacturer’s
procedure. The assay was performed by using a luminometer (Clarity
Luminescence Microplate Reader, Fisher Bioblock Scientiﬁc, Illkirsch,
France). In addition, cell viability was assessed using the trypan-blue
exclusion method.2.7. Luciferase activity
To measure the transcriptional activity of NF-jB, cells were cotrans-
fected with the 0.4SK-luc plasmid (a generous gift of Dr. A. Israe¨l,
Institut Pasteur, France) containing the transcriptional regulatory ele-
ment of the IjBa promoter with its 3 jB sites in front of the luciferase
gene [26] and either the hairpin NF-jB decoy ODN or the hairpin
scrambled ODN (0.5 lg, corresponding to 100 nM) combined to lipo-
somes. Cells were lysed 48 h later for 30 min with a lysis buﬀer contain-
ing 10 mM Tris–HCl, pH 7.5, 1 mM EDTA, 100 mM NaCl, 1% NP40
and 1 mM dithiothreitol. The lysates were clariﬁed by centrifugation
and assayed for luciferase activity using the Luciferase Assay System
(Promega) and a luminometer. Protein concentrations were measured
using the Bradford method. The experiments were done in triplicate.
2.8. Immunoﬂuorescence
Cellular uptake and subcellular localization of the Cy3-labeled hair-
pin NF-jB decoy ODN were analysed on cells grown for 24 h on glass
slides (Lab-Tek, Nunc, USA). Cells were washed twice in PBS, ﬁxed in
3.7% formaldehyde in PBS for 15 min, permeabilized in 0.1% Triton
X-100 for 15 min and blocked with 5% FCS, 0.1% Tween in PBS for
1 h. Cells were incubated with the primary antibody (anti-pl05/p50,
dilution 1:100, Cell Signaling) for 1 h. The signal was ampliﬁed by
the formation of the streptavidin–biotin complex (Universal LSAB
kit, Dako France SAS, Trappes, France) using Alexa Fluor 488-
labeled streptavidin (Invitrogen-Molecular Probes) diluted at 1:500
(90 min incubation). After counterstaining with DAPI, coverslips were
mounted onto glass slides in Vectashield (Vectorlabs, Clinisciences,
Montrouge, France). Fluorescent images were digitally acquired using
a Zeiss Axioplan2 Deconvolution microscope (CarlZeiss, Le Pecq, France)
and analysed with Metafer4 (Metasystems, Altlussheim, Germany).
2.9. Oligonucleotide pull-down and Western blotting
Nuclear protein extracts were obtained as follows: 20 million cells
were resuspended in lysis buﬀer containing 20 mM HEPES, pH 7.4,
1 mM MgCl2, 10 mM KCl, 0.3% NP40, 0.5 mM dithiothreitol,
0.1 mM EDTA and protease inhibitors (Compete, Boerhinger) at
4 C for 5 min. The lysates were centrifuged at 12000 · g for 20 min
at 4 C, and the supernatants containing the cytoplasmic proteins were
discarded. The pellets were resuspended in the cell lysis buﬀer adjusted
with 20% glycerol and 0.35 M NaCl for 30 min at 4 C. After centrifu-
gation at 20000 · g for 5 min at 4 C, the supernatants were stored at
80 C. For pull-down assays, 100–200 lg of nuclear protein extracts
were incubated for 30 min at 4 C in binding buﬀer containing: 1%
NP40 (Sigma), 50 mM HEPES, pH 7.6 (Euromedex), 140 mM NaCl
(Sigma), salmon sperm DNA (1 lg/assay) and 1 lg of the biotinylated
hairpin decoy ODN. The complexes were captured by incubating with
50 ll of avidin–sepharose beads (neutravidin, Pierce) for 2 h at 4 C,
washed three times with Tris-buﬀered saline (TBS) 20 mM NaCl (Sig-
ma), 500 mM Tris–HCl, pH 8 (Euromedex), and once with TBS-0.1%
Tween (TBS-T). After resuspension in sample buﬀer, complexes were
separated on a SDS–polyacrylamide (10%) gel, and subjected to immu-
noblotting using anti-p50 NF-jB (Cell Signaling) followed by chemilu-
minescence (LumiGLO, Cell Signaling) and autoradiography (X-Omat
R, Kodak).3. Results
3.1. Eﬃcient lipid-mediated delivery of NF-jB hairpin decoy
to MCF7 and SW480 tumour cells
To determine lipids/decoy ODN ratios that result in optimal
cellular uptake of the hairpin NF-jB decoy into SW480 cells,
we prepared mixtures of cationic lipid/neutral colipid (DOPE)
and decoy ODN at diﬀerent weight ratios and transfected cells
with increasing concentrations of FITC-labeled hairpin NF-jB
decoy ODN. The intensity of FITC ﬂuorescence was measured
by ﬂow cytometry: the uptake of the decoy in cells showed
concentration dependence with no apparent saturation in the
hairpin NF-jB decoy ODN concentration range studied
(Fig. 1A). Similar results were obtained with MCF7 cells
(not shown).
Fig. 1. Cellular uptake of the hairpin NF-jB decoy ODN. (A) Eﬃcient uptake of the decoy ODN by SW480 cells using decoy/lipid complexes. The
complexes were transfected using FITC-labeled NF-jB decoy/positively charged lipid/colipid complexes. After 6 h of incubation, the cells were
placed in fresh culture medium containing 10% serum for 24 h. Fluorescence intensity was measured by ﬂow cytometry after a treatment with lipids
alone (liposomes/ODN ratio 1/0) or lipids combined to increasing concentrations of FITC-labeled hairpin NF-jB decoy ODN from 100 nM to
400 nM (liposomes/ODN ratio 1/0.5, 1/1, 1/2). (B) Eﬀect of the treatment of MCF7 cells with lipids alone. Cells were treated with lipids for 6 h and
analysed for annexin V binding and PI uptake after 24 h of culture: 0: no lipids: 3% dead cells, 0.5 lg of lipids: 3% dead cells, 1 lg of lipids: 6% dead
cells, 2 lg of lipids: 9% dead cells.
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with NF-jB hairpin decoy
MCF7 and SW480 cells were treated with the low molecular
weight inhibitor of NF-jB (Bay-11) to verify that their growth
was dependent on functional NF-jB. Concentrations in the
micromolar range were suﬃcient to kill cells within hours (data
not shown). Several lipid concentrations, ranging between 5
and 20 lg/ml were tested for their toxicity to MCF7 cells.
The resultant content in dead cells, measured by annexin V
binding and PI uptake, varied between 3% and 9% (Fig. 1B).
After treatment of MCF7 cells with hairpin NF-jB decoy
for 6 h, followed by a 24 h incubation, the proportion of dead
cells increased over 2-fold when the ODN/lipid complexes ra-
tio was 1/1, and reached 5-fold when the ODN/lipid complexes
ratio was 2/2 (Fig. 2A, see histogram in 2B). In the case of
SW480 cells, addition of lipids alone increased cell death by
10% (see Fig. 2C) and treatment with hairpin decoy ODN
(lipid/ODN ratio equal to 1/0.5) for 30 h resulted in the highest
rate of cell death (Fig. 2C). Using the trypan blue exclusion
method we found a 2-fold increase in dead cells with a ratio
of 1/0.5 and a 2.5 increase with a ratio of 1/1 (Fig. 2D). In
the 2C4 ﬁbrosarcoma cell line, the transfection of hairpin
NF-jB decoy ODN did not induce cell death (Fig. 2E)
although the hairpin NF-jB decoy ODN could eﬃciently enter
the cells (Fig. 2F). On the other hand, curcumin, a chemical
with multiple targets [27], could eﬃciently kill the 2C4 cells
(Fig. 2E).
To further characterize the eﬀect of hairpin NF-jB decoy
ODN on cell viability, intracellular ATP was measured byluminometry. Twenty four hours after the MCF7 cells had
been treated with the hairpin NF-jB decoy ODN (ratio 2/2),
a 2-fold decrease in cell viability was observed (Fig. 3A). With
the SW480 cells, a 3-fold decrease was observed after 24 h of
treatment with the hairpin NF-jB decoy ODN (ratio 1/0.5)
(Fig. 3B). In control experiments using the hairpin scram-
bled ODN (ratio 1/0.5) there was no eﬀect on viability in nei-
ther cell line (Fig. 3C) nor did cell death increase (data not
shown).4. The hairpin NF-jB decoy ODN interacts with the p50
subunit of NF-jB
The decreased cell viability and the increased cell death
caused by the treatment with the hairpin NF-jB decoy ODN
could potentially be a consequence of events unrelated to
NF-jB. To test whether the hairpin NF-jB decoy ODN inter-
acts with NF-jB we performed pulldown assays using a biotin-
ylated version of the hairpin NF-jB decoy ODN and nuclear
protein extracts of SW480 cells. The results show that the hair-
pin NF-jB decoy ODN formed a complex with the p50 sub-
unit (Fig. 4A), this complex was not detectable when nuclear
protein extracts were ﬁrst incubated with an excess of non-bio-
tinylated hairpin NF-jB decoy ODN or when a biotinylated
hairpin scrambled decoy ODN was used. These data demon-
strate the ability of the hairpin NF-jB decoy ODN to interact
with the p50 subunit of NF-jB in cellular extracts. To verify
that this interaction also occurred within the cells, ﬂuorescence
Fig. 2. Increased cell death of MCF7 and SW480 cells treated with hairpin NF-jB decoy ODN. (A) MCF7 cells were treated with empty lipid
complexes (liposomes/ODN ratio 0/0), or lipid complexes combined with hairpin NF-jB decoy ODN at the liposomes/ODN ratios of 0.5/0.5, 1/1 or
2/2 for 6 h and analysed by ﬂow cytometry for annexin V binding and PI uptake after 24 h of culture; a typical experiment is shown. (B) Histograms
of several experiments of cell death induction by the hairpin NF-jB decoy ODN. Results are expressed as fold of dead cells over control (lipids
alone). (C) Cell death induced by the ODN in SW480 cells as measured by annexin V binding. Cells were treated for 6 h with lipid complexes
combined with hairpin NF-jB decoy ODN at the following liposomes/ODN ratios (lg/lg): 0/0, 1/0; 1/0.5 and 1/1, and analysed for annexin V
binding by ﬂow cytometry, after 24 h of culture; The combined results from several experiments are expressed as fraction of control (untreated cells).
(D) Cell death induced by the ODN in SW480 cells as determined by the trypan blue exclusion assay. Results are expressed as fold of dead cells over
control. A typical result is shown. (E) The 2C4 cells, which do not depend on the activity of NF-jB for their survival, were treated with empty
liposomes (1/0), liposomes either combined to hairpin NF-jB decoy ODN 1/0.5 or to a hairpin scrambled ODN at the same concentrations or with
curcumin at 40 lM. Viable cells were counted using the trypan blue exclusion assay. The relative amount of dead cells (treated cells/control cells) is
shown, the experiment was repeated three times. (F) The 2C4 cells were transfected with the FITC-labeled hairpin NF-jB decoy ODN 1/0.5 or
liposomes alone (1/0) and ﬂuorescence intensity measured as in Fig. 1. The result is expressed as a fraction of the control.
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beled version of the hairpin NF-jB decoy ODN under condi-
tions similar to those described for the induction of cell death.
After transfection, the p50 subunit was mainly detected in the
Fig. 3. The hairpin NF-jB decoy ODN reduces the viability of MCF7
and SW480 cells. MCF7 (A) and SW480 cells (B) were treated with
hairpin NF-jB decoy ODN under the conditions used in Fig. 2 and cell
viability determined by measuring the intracellular concentration of
ATP on a luminometer. A control experiment included SW480 cells
treated with either lipid complexes combined with the hairpin NF-jB
decoy ODN or the hairpin scrambled ODN, at 1/0.5, or free lipid
complexes (1/0). After 24 h of culture, ODN concentration-dependent
decreased intracellular ATP was observed reﬂecting reduced viability
of the cells. The eﬀect was maximal between 0.5 lg (100 nM) and 1 lg
(200 nM) of ODN (C). The experiment was performed in triplicate.
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jB decoy ODN was found to be homogeneously distributed
within the cytoplasm of most of the cells. Superimposition of
the p50 (green ﬂuorescence) and the Cy3 -labeled hairpin
NF-jB decoy ODN (red ﬂuorescence) images yielded areas
of yellow color, suggesting that p50 and hairpin NF-jB decoy
ODN colocalized in the cytoplasm (Fig. 4B). In the SW480
cells, the p50 subunit and the Cy3-labeled hairpin NF-jB de-
coy ODN were also detected in the cytoplasm (Fig. 4C, panels
a and c). And after a treatment of the cells with TNFa, the p50
subunit ﬂuorescence was detected in the nucleus (Fig. 4C,
panel b), however, in cells that had also been treated with
the Cy3-labeled hairpin NF-jB decoy ODN, the p50 subunit
was detected in the cytoplasm, but not in the nucleus
(Fig. 4C, panel d, arrow). These data support the notion that
the hairpin NF-jB decoy ODN is engaged in direct binding
with the p50 within the cell.5. The hairpin NF-jB decoy ODN inhibits NF-jB
transcriptional activity
To determine whether the hairpin NF-jB decoy ODN could
inhibit the transcriptional activity of NF-jB, the cells were
transfected with a luciferase reporter cDNA under the control
of a promoter containing 3 NF-jB recognition sites and the
intensity of the luminescence was measured. The results
showed a 70% decrease of the luminescence in cells that were
transfected with the hairpin NF-jB decoy ODN, whereas there
was no inhibition when cells were transfected with the hairpin
scrambled ODN (Fig. 5).6. Discussion
The main goal of this work was to examine the ability of a
hairpin NF-jB decoy ODN to induce cell death in cancer cells
and to determine whether this eﬀect correlated with the inter-
action of the hairpin NF-jB decoy ODN with NF-jB. The re-
sults obtained demonstrated that the decoy induced cell death
in the cell lines tested and that it formed complexes with the
p50 subunit of NF-jB, suggesting that it functions by directly
blocking it in the cells. Inhibition of gene expression by target-
ing diﬀerent transcription factors by ODNs has been shown to
eﬃciently inhibit the growth of cancer cells [28–31]. The study
attempted to investigate in more detail the mechanism of the
anti-proliferative and the eﬀects on cell death of NF-jB decoy
ODN at the cellular level in NF-jB-dependent tumour cells.
The decoy ODNs had aliphatic linker chains attached at both
3 0 and 5 0 termini to increase their resistance to nucleases within
the cells, allowing to use the lowest possible concentrations. In-
deed, in experiments conducted with the same hairpin decoy
ODN without any end-substitutions there was no detectable
eﬀect on cell death (not shown).
The dependence of the two cancer cell lines, MCF7 and
SW480, on the activity of NF-jB for their growth [3,32,33]
was veriﬁed using Bay 11 [5]. In order to be able to study
the cells we chose to use the hairpin decoy ODNs at low con-
centrations. The two cell lines showed a considerable increase
of cell death levels after transfection with the hairpin NF-jB
decoy ODN; their sensitivity to hairpin decoy ODN were
somewhat similar: with MCF7 cells, an increase was still noted
at 2/2 but the toxicity of lipid itself did not allow to use higher
amounts, whereas with SW480 the ratios of 0.5/1 and 1/1 gave
identical results, as well as 1/2 (not shown), indicating that
optimal conditions were reached. In contrast, in the 2C4 ﬁbro-
sarcoma cell line, which shows no dependence on NF-jB tran-
scriptional activity [34] NF-jB decoy ODN had no eﬀect.
Altogether, these results show that NF-jB-dependent cells
are sensitive to a treatment by a hairpin NF-jB decoy ODN.
The use of lipids was necessary to enable the incorporation
of the decoy ODN into the cells, and when added alone the lip-
ids showed low toxicity to the cells. The lipid complexes en-
abled homogeneous distribution of the Cy3-labeled ODN in
the cytoplasm of most of the cells. The observation of a con-
centration-dependent inhibition of NF-jB, together with the
absence of eﬀect of a hairpin scrambled ODN suggests that
direct interaction of the hairpin NF-jB decoy ODN with the
DNA-binding region of NF-jB was required for inhibition.
Indeed, the Cy3-labeled version of the hairpin NF-jB decoy
ODN was found to colocalize with the p50 subunit of NF-jB
Fig. 4. Demonstration of the interaction of the hairpin NF-jB decoy ODN with the p50 subunit. (A) Pull-down assay with the hairpin NF-jB decoy
ODN. Nuclear extracts (100 lg) were incubated with a biotinylated version of the hairpin NF-jB decoy ODN (1 lg) (lane 1), or a biotinylated
hairpin scrambled ODN (1 lg) (lane 2). In one assay, an excess of non-biotinylated-NF-jB decoy ODN was added before the biotinylated ODN
(lane 3). The complexes were analysed by Western blotting using anti-p50 NF-jB antibody. The amount of NF-jB p50 subunit in the nuclear extract
is shown (input) (lane 4). Cellular uptake of the hairpin NF-jB decoy ODN and colocalization with the p50 subunit of NF-jB: (B), in MCF7 cells;
the subcellular location of the p50 subunit NF-jB was analysed by ﬂuorescence microscopy after ﬂuorescent immunostaining (Alexa 488 green) and
was mostly cytoplasmic (a, arrow). The distribution of the Cy3-labeled hairpin NF-jB decoy ODN, analysed under conditions identical to those
described in Fig. 1, was homogenous and cytoplasmic (b, arrow). The merge (c) shows cytoplasmic colocalization of the p50 subunit and the Cy3-
labeled NF-jB decoy ODN (arrow). (C) In SW480 cells; the p50 subunit of NF-jB was cytoplasmic in non-treated cells (panel a) and nuclear in
TNFa-treated cells (panel b). The Cy3-labeled NF-jB decoy ODN was in the cytoplasm (c, arrow). The merge shows the colocalization of the labeled
hairpin NF-jB decoy ODN and the NF-jB p50 subunit (d, arrow), and suggests inhibition of the TNFa-induced nuclear translocation of the p50
subunit by the hairpin NF-jB decoy ODN. Magniﬁcation: 100·.
Fig. 5. Inhibition of the transcriptional activity of NF-jB by the
hairpin NF-jB decoy ODN in SW480 cells. SW480 cells were
cotransfected with a 0.4SK-luc plasmid and either hairpin NF-jB
decoy ODN or a hairpin scrambled ODN, and the luciferase activity
after 24 h incubation with the decoy ODN measured. Relative NF-jB
transcriptional activity in transfected cells is shown. Each transfection
experiment was done in triplicate.
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ODN was apparently able to prevent the TNFa-induced trans-
location of the p50 subunit to the nucleus. As suggested by theﬂuorescence microscopy results, the treatment with hairpin
NF-jB decoy ODN resulted in trapping the p50 subunit exclu-
sively in the perinuclear area in the cytoplasm. The direct inter-
action of the ODN and NF-jB was also demonstrated by the
eﬃcient pulldown of the p50 subunit of NF-jB from nuclear
extracts with a biotin-tagged version of the hairpin NF-jB
decoy ODN. The observed reduced activity of the luciferase re-
porter construct containing an NF-jB response element in
cells treated with the hairpin NF-jB decoy ODN suggested
that p50-hairpin decoy ODN interaction was responsible for
the inhibition of the transcriptional activity of NF-jB.
Overall, our results indicate that trapping of p50 in the cyto-
plasm could be suﬃcient to eﬃciently inhibit NF-jB. Previous
reports using NF-jB decoy drew somewhat diﬀerent conclu-
sions: in some reports the trapping of the hairpin NF-jB decoy
ODN to the cytoplasm is considered to be responsible for its
absence of inhibitory eﬃciency [35,36]; in another report the
eﬃcient inhibition of NF-jB, measured by gel retardation
assay is thought to be independent from the nuclear transloca-
tion of the transcription factor [37]. These observed diﬀerences
may be due in part to variations in the experimental condi-
tions. Nevertheless, the mechanism of activation of NF-jB
involves its interaction with target DNA mostly as a heterodi-
meric complex comprising the p50 and p65 subunits, an inter-
action which is thought to take place in the cytoplasm once the
complex has been freed from the I-jB inhibitory subunit. Crys-
tallographic studies have also shown that the I-jB subunit
C. Laguillier et al. / FEBS Letters 581 (2007) 1143–1150 1149masks the nuclear localization signal (NLS) of the p65 subunit
but not that of the p50 subunit [38], thus it is unclear why the
hairpin decoy ODN used in this study is so eﬃcient. It is pos-
sible that the ODN’s high aﬃnity for the p50 subunit interferes
with the cytoplasm/nucleus equilibrium shuttling [39,40] of the
NF-jB complex. Because of the diﬀerences between relative
aﬃnities of anti-p50 and anti-p65 antibodies it was problem-
atic to faithfully assess the content of the hairpin decoy
ODN/NF-jB subunit complex obtained in pull-down assays:
in our hands the p65 subunit was present in these complexes
but in lower amounts (not shown). Nevertheless, the most
abundant forms of NF-jB complexes are the p50/p65 hetero-
and the p50/p50 homodimers, the p50/p65 heterodimer being
the most transcriptionally active form [41].
The mechanism of cell death induced by the hairpin NF-jB
decoy ODN remains unclear. While trypan blue exclusion, PI
and ATP viability tests showed clear eﬀects of the hairpin NF-
jB decoy ODN, the Annexin V binding and the detection of
apoptotic bodies by DAPI were negative. Recent studies
showed that several forms of programmed cell death exist
apart from apoptosis [42,43]. The absence of PARP cleavage
in the hairpin decoy treated cells suggests the involvement of
a form of cell death diﬀerent from apoptosis (data not shown).
In conclusion, we ﬁnd that the eﬃcient induction of cell
death by a hairpin NF-jB decoy ODN involves its direct inter-
action with the transcription factor and its subsequent cyto-
plasmic trapping. This provides a basis for the modelling of
high aﬃnity inhibitory decoys interacting with a transcription
factor’s DNA-binding region.
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